Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis of radiopharmaceuticals containing short-lived radionuclides: Comprehensive progress report, March 1, 1986-February 28, 1989

Technical Report ·
OSTI ID:6950030
The primary objective of the DOE Nuclear Medicine Program at The University of Tennessee is the creation of new methods for intoducing short-lived isotopes into agents for use in PET and SPECT. A portion of our effort is directed toward the design and in vivo quantitation of boron-containing neutron therapy agents. The uniqueness of the program is its focus on the design of new chemistry (molecular architecture) and technology as opposed to the application of known reactions to the synthesis of specific radiopharmaceuticals. The following topics are outlined in this paper: new isotope incorporation reactions utilizing nitrogen 13, oxygen 15, and carbon 11; technetium-boron complexes; boron-neutron-capture.
Research Organization:
Tennessee Univ., Knoxville (USA). Dept. of Chemistry
DOE Contract Number:
FG05-86ER60434
OSTI ID:
6950030
Report Number(s):
DOE/ER/60434-3; ON: DE88011524
Country of Publication:
United States
Language:
English